RNS Number : 2074U
Breedon Group PLC
24 March 2023





24 March 2023



("Breedon" or the "Company")


Holdings in the Company


Breedon has been informed by Abicad Holding Limited ("Abicad") that on 24 March 2023, Abicad agreed to acquire 6,536,790 ordinary shares of no par value ("Ordinary Shares") in the issued share capital of Breedon at a price of 73.55 pence per Ordinary Share (the "Transaction").  On settlement of the Transaction (expected on 28 March 2023), Abicad will hold 176,795,429 Ordinary Shares, equivalent to 10.43% of Breedon's total issued share capital. Abicad's current board representative is Amit Bhatia, who is the Non-executive Chairman of Breedon.


As at today there are 1,694,399,580 Ordinary Shares in issue, none of which are held in treasury.  This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.




Breedon Group plc                                        

James Atherton-Ham, Group General Counsel           01332 694010


Numis Securities (NOMAD and Joint Broker)          020 7260 1000

Ben Stoop

Oliver Hardy (NOMAD)


HSBC (Joint Broker)                                               020 7991 8888

Sam McLennan

Joe Weaving


MHP (Public Relations Adviser)                              020 3128 8613

Reg Hoare

Rachel Farrington

Charles Hirst


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.